Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional)
This grant opportunity focuses on addressing new and evolving drug threats like xylazine and nitazenes, which may not be detectable with standard drug testing strips. Instead of relying on these strips, the analysis needs to be conducted using methods that are both sensitive and capable of testing various types of samples. This is crucial because testing strips for these emerging drugs might n…
Emerging threats continuously evolve. Xylazine, nitazenes, and other future threats are making their way or are already in the drug supply. Understanding them requires analyzing real world samples. Typically, testing strips are used to detect drug for which such strip exists, as the strips are f…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers